A combination of biophysical, biochemical, and computational techniques was used to delineate mechanistic differences between the platinum-acridine hybrid agent [PtCl(en)(L)](NO(3))(2) (complex 1, en = ethane-1,2-diamine, L = 1-[2-(acridin-9-ylamino)ethyl]-1,3-dimethylthiourea) and a considerably more potent second-generation analogue containing L' = N-[2-(acridin-9-ylamino)ethyl]-N-methylpropionamidine (complex 2). Calculations at the density functional theory level provide a rationale for the binding preference of both complexes for guanine-N7 and the relatively high level of adenine adducts observed for compound 1. A significant rate enhancement is observed for binding of the amidine-based complex 2 with DNA compared with the thiourea-based prototype 1. Studies conducted with chemical probes and on the bending and unwinding of model duplex DNA suggest that adducts of complex 2 perturb B-form DNA more severely than complex 1, however, without denaturing the double strand and significantly less than cisplatin. Circular and linear dichroism spectroscopies and viscosity measurements suggest that subtle differences exist between the intercalation modes and adduct geometries of the two complexes. The adducts formed by complex 2 most efficiently inhibit transcription of the damaged DNA by RNA polymerase II. Not only do complexes 1 and 2 cause less distortion to DNA than cisplatin, they also do not compromise the thermodynamic stability of the modified duplex. This leads to a decreased or negligible affinity of HMG domain proteins for the adducts formed by either Pt-acridine complex. In a DNA repair synthesis assay the lesions formed by complex 2 were repaired less efficiently than those formed by complex 1. These significant differences in DNA adduct formation, structure, and recognition between the two acridine complexes and cisplatin help to elucidate why compound 2 is highly active in cisplatin-resistant, repair proficient cancer cell lines.

Institute of Biophysics Academy of Sciences of the Czech Republic vvi Kralovopolska 135 CZ 61265 Brno Czech Republic

Zobrazit více v PubMed

Kelland L. The resurgence of platinum-based cancer chemotherapy. Nature Rev Cancer. 2007;7:573–584. PubMed

Kalinowska-Lis U, Ochocki J, Matlawska-Wasowska K. Trans geometry in platinum antitumor complexes. Coord Chem Rev. 2008;252:1328–1345.

Hall MD, Dolman RC, Hambley TW. Platinum(IV) anticancer complexes. In: Sigel A, Sigel H, editors. Metal Ions in Biological Systems. Vol. 42. Marcel Dekker, Inc; New York, Basel: 2004. pp. 297–322. PubMed

Mangrum JB, Farrell NP. Excursions in polynuclear platinum DNA binding. Chem Commun. 2010;46:6640–6650. PubMed PMC

Bednarski PJ, Mackay FS, Sadler P. Photoactivatable platinum complexes. Anti- Cancer Agents Med Chem. 2007;7:75–93. PubMed

Kostova I. Ruthenium complexes as anticancer agents. Curr Med Chem. 2006;13:1085–1107. PubMed

Peacock AFA, Habtemariam A, Fernandez R, Walland V, Fabbiani FPA, Parsons S, Aird RE, Jodrell DI, Sadler PJ. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions. J Am Chem Soc. 2006;128:1739–1748. PubMed

Liu Z, Habtemariam A, Pizarro AM, Fletcher SA, Kisova A, Vrana O, Salassa L, Bruijnincx PCA, Clarkson GJ, Brabec V, Sadler PJ. Organometallic half-sandwich iridium anticancer complexes. J Med Chem. 2011;54:3011–3026. PubMed

Jung Y, Lippard SJ. Direct cellular responses to platinum-induced DNA damage. Chem Rev. 2007;107:1387–1407. PubMed

Cepeda V, Fuertes M, Castilla J, Alonso C, Quevedo C, Perez JM. Biochemical mechanisms of cisplatin cytotoxicity. Anti-Cancer Agents Med Chem. 2007;7:3–18. PubMed

Vrana O, Brabec V, Kleinwächter V. Polarographic studies on the conformation of some platinum complexes: relations to anti-tumour activity. Anti-Cancer Drug Des. 1986;1:95–109. PubMed

Bowler BE, Lippard SJ. Modulation of platinum antitumor drug binding to DNA by linked and free intercalators. Biochemistry. 1986;25:3031–3038. PubMed

Petitjean A, Barton JK. Tuning the DNA reactivity of cis-platinum: Conjugation to a mismatch-specific metallointercalator. J Am Chem Soc. 2004;126:14728–14729. PubMed

Baruah H, Barry CG, Bierbach U. Platinum-intercalator conjugates: From DNAtargeted cisplatin derivatives to adenine binding complexes as potential modulators of gene regulation. Curr Topics Med Chem. 2004;4:1537–1549. PubMed

Liu HK, Parkinson JA, Bella J, Wang F, Sadler PJ. Penetrative DNA intercalation and G-base selectivity of an organometallic tetrahydroanthracene RuII anticancer complex. Chem Sci. 2010;1:258–270.

Liu HK, Sadler PJ. Metal complexes as DNA intercalators. Acc Chem Res. 2011;44:349–359. PubMed

Guddneppanavar R, Bierbach U. Adenine-N3 in the DNA minor groove - An emerging target for platinum containing anticancer pharmacophores. Anti-Cancer Agents Med Chem. 2007;7:125–138. PubMed

Takahara PM, Rosenzweig AC, Frederick CA, Lippard SJ. Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin. Nature. 1995;377:649–652. PubMed

Kartalou M, Essigmann JM. Recognition of cisplatin adducts by cellular proteins. Mutation Res. 2001;478:1–21. PubMed

Barry CG, Baruah H, Bierbach U. Unprecedented monofunctional metalation of adenine nucleobase in guanine- and thymine-containing dinucleotide sequences by a cytotoxic platinum-acridine hybrid agent. J Am Chem Soc. 2003;125:9629–9637. PubMed

Martins ET, Baruah H, Kramarczyk J, Saluta G, Day CS, Kucera GL, Bierbach U. Design, synthesis, and biological activity of a novel non-cisplatin-type platinum-acridine pharmacophore. J Med Chem. 2001;44:4492–4496. PubMed

Baruah H, Rector CL, Monnier SM, Bierbach U. Mechanism of action of noncisplatin type DNA-targeted platinum anticancer agents: DNA interactions of novel acridinylthioureas and their platinum conjugates. Biochem Pharmacol. 2002;64:191–200. PubMed

Barry CG, Day CS, Bierbach U. Duplex-promoted platination of adenine-N3 in the minor groove of DNA: Challenging a longstanding bioinorganic paradigm. J Am Chem Soc. 2005;127:1160–1169. PubMed

Baruah H, Wright MW, Bierbach U. Solution structural study of a DNA duplex containing the guanine-N7 adduct formed by a cytotoxic platinum-acridine hybrid agent. Biochemistry. 2005;44:6059–6070. PubMed

Budiman ME, Alexander RW, Bierbach U. Unique base-step recognition by a platinum-acridinylthiourea conjugate leads to a DNA damage profile complementary to that of the anticancer drug cisplatin. Biochemistry. 2004;43:8560–8567. PubMed

Ma Z, Choudhury JR, Wright MW, Day CS, Saluta G, Kucera GL, Bierbach U. A non-cross-linking platinum-acridine agent with potent activity in nonsmall- cell lung cancer. J Med Chem. 2008;51:7574–7580. PubMed PMC

Damsma GE, Alt A, Brueckner F, Carell T, Cramer P. Mechanism of transcriptional stalling at cisplatin-damaged DNA. Nature Struct Mol Biol. 2007;14:1127–1133. PubMed

Brabec V, Kasparkova J. Role of DNA repair in antitumor effects of platinum drugs. In: Hadjiliadis N, Sletten E, editors. Metal Complex - DNA Interactions. Wiley; Chichester, UK: 2009. pp. 175–208.

Brabec V, Palecek E. Interaction of nucleic acids with electrically charged surfaces. II. Conformational changes in double-helical polynucleotides. Biophys Chem. 1976;4:76–92. PubMed

Brabec V, Palecek E. The influence of salts and pH on polarographic currents produced by denatured DNA. Biophysik. 1970;6:290–300. PubMed

Stros M. DNA bending by the chromosomal protein HMG1 and its high mobility group box domains. Effect of flanking sequences. J Biol Chem. 1998;273:10355–10361. PubMed

Stros M. Two mutations of basic residues within the N-terminus of HMG-1 B domain with different effects on DNA supercoiling and binding to bent DNA. Biochemistry. 2001;40:4769–4779. PubMed

Kasparkova J, Delalande O, Stros M, Elizondo-Riojas MA, Vojtiskova M, Kozelka J, Brabec V. Recognition of DNA interstrand cross-link of antitumor cisplatin by HMGB1 protein. Biochemistry. 2003;42:1234–1244. PubMed

Reardon JT, Vaisman A, Chaney SG, Sancar A. Efficient nucleotide excision repair of cisplatin, oxaliplatin, and bis-aceto-ammine-dichloro-cyclohexylamineplatinum( IV) (JM216) platinum intrastrand DNA diadducts. Cancer Res. 1999;59:3968–3971. PubMed

Kim SD, Vrana O, Kleinwächter V, Niki K, Brabec V. Polarographic determination of subnanogram quantities of free platinum in reaction mixture with DNA. Anal Lett. 1990;23:1505–1518.

Kasparkova J, Mellish KJ, Qu Y, Brabec V, Farrell N. Site-specific d(GpG) intrastrand cross-links formed by dinuclear platinum complexes. Bending and NMR studies. Biochemistry. 1996;35:16705–16713. PubMed

Baruah H, Day CS, Wright MW, Bierbach U. Metal-intercalator-mediated selfassociation and one-dimensional aggregation in the structure of the excised major DNA adduct of a platinum-acridine agent. J Am Chem Soc. 2004;126:4492–4493. PubMed

Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA, Jr, Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Klene M, Li X, Knox JE, Hratchian HP, Cross JB, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Ayala PY, Morokuma K, Voth GA, Salvador P, Dannenberg JJ, Zakrzewski VG, Dapprich S, Daniels AD, Strain MC, Farkas O, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Ortiz JV, Cui Q, Baboul AG, Clifford S, Cioslowski J, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Challacombe M, Gill PMW, Johnson B, Chen W, Wong MW, Gonzalez C, Pople JA. Gaussian 03, Revision A.1. Gaussian, Inc; Pittsburgh, PA: 2003.

Becke AD. Density-functional thermochemistry. 3. The role of exact exchange. J Chem Phys. 1993;98:5648–5652.

Lee C, Yang W, Parr RG. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B. 1988;37:785–789. PubMed

Hay PJ, Wadt WR. Ab initio effective core potentials for molecular calculations. Potentials for K to Au including the outermost core orbitals. J Chem Phys. 1985;82:299–310.

Dunning THJ, Hay PJ. Gaussian basis sets for molecular calculations. Modern Theor Chem. 1977;3:1–27.

Miertus S, Scrocco E, Tomasi J. Electrostatic interaction of a solute with a continuum. A direct utilizaion of AB initio molecular potentials for the prevision of solvent effects. Chem Phys. 1981;55:117–129.

Rodger A. Linear dichroism. Methods Enzymol. 1993;226:232–258. PubMed

Rodger A, Norden B. Circular Dichroism and Linear Dichroism. Oxford University Press; Oxford, New York, Tokyo: 1997.

Leharne SA, Chowdhry BZ. Thermodynamic background to differential scanning calorimetry. In: Ladbury JE, Chowdhry BZ, editors. Biocalorimetry: Applications of Calorimetry in the Biological Sciences. J. Wiley & Sons; Chichester, UK: 1998. pp. 157–182.

Hofr C, Farrell N, Brabec V. Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex. Nucleic Acids Res. 2001;29:2034–2040. PubMed PMC

Hofr C, Brabec V. Thermal and thermodynamic properties of duplex DNA containing site-specific interstrand cross-link of antitumor cisplatin or its clinically ineffective trans isomer. J Biol Chem. 2001;276:9655–9661. PubMed

Brabec V, Sip M, Leng M. DNA conformational distortion produced by site-specific interstrand cross-link of trans-diamminedichloroplatinum(II) Biochemistry. 1993;32:11676–11681. PubMed

Bellon SF, Coleman JH, Lippard SJ. DNA unwinding produced by site-specific intrastrand cross- links of the antitumor drug cis-diamminedichloroplatinum(II) Biochemistry. 1991;30:8026–8035. PubMed

Kasparkova J, Farrell N, Brabec V. Sequence specificity, conformation, and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes. J Biol Chem. 2000;275:15789–15798. PubMed

Malina J, Kasparkova J, Natile G, Brabec V. Recognition of major DNA adducts of enantiomeric cisplatin analogs by HMG box proteins and nucleotide excision repair of these adducts. Chem Biol. 2002;9:629–638. PubMed

Choudhury J, Rao L, Bierbach U. Rates of intercalator-driven platination of DNA determined by a restriction enzyme cleavage inhibition assay. J Biol Inorg Chem. 2011;16:373–380. PubMed PMC

Kostrhunova H, Vrana O, Suchankova T, Gibson D, Kasparkova J, Brabec V. Different features of the DNA binding mode of antitumor cis-amminedichlorido(cyclohexylamine)platinum(II) (JM118) and cisplatin in vitro. Chem Res Toxicol. 2010;23:1833–1842. PubMed

Baruah H, Bierbach U. Biophysical characterization and molecular modeling of the coordinative-intercalative DNA monoadduct of a platinum-acridinylthiourea agent in a site-specifically modified dodecamer. J Biol Inorg Chem. 2004;9:335 – 344. PubMed

Schipper PE, Norden B, Tjerneld F. Determination of binding geometry of DNAadduct systems through induced circular-dichroism. Chem Phys Lett. 1980;70:17–21.

Wirth M, Buchardt O, Koch T, Nielsen PE, Norden B. Interactions between DNA and mono(aminoacridines), bis(aminoacridines), tris(aminoacridines), tetrakis(aminoacridines), and hexakis(aminoacridines) - a linear and circular-dichroism, electric orientation relaxation, viscometry, and equilibrium study. J Am Chem Soc. 1988;110:932–939.

Rodger A, Marington R, Geeves MA, Hicks M, de Alwis L, Halsall DJ, Dafforn TR. Looking at long molecules in solution: what happens when they are subjected to Couette flow? Phys Chem Chem Phys. 2006;8:3161–3171. PubMed

Brabec V. DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair. Prog Nucleic Acid Res Mol Biol. 2002;71:1–68. PubMed

Kasparkova J, Brabec V. Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum( II) and its trans isomer by DNA- binding proteins. Biochemistry. 1995;34:12379–12387. PubMed

Kasparkova J, Novakova O, Vrana O, Intini F, Natile G, Brabec V. Molecular aspects of antitumor effects of a new platinum(IV) drug. Mol Pharmacol. 2006;70:1708–1719. PubMed

Cullinane C, Mazur SJ, Essigmann JM, Phillips DR, Bohr VA. Inhibition of RNA polymerase II transcription in human cell extracts by cisplatin DNA damage. Biochemistry. 1999;38:6204–6212. PubMed

Bagchi MK, Tsai SY, Weigel NL, Tsai MJ, O’Malley BW. Regulation of in vitro transcription by progesterone receptor. Characterization and kinetic studies. J Biol Chem. 1990;265:5129–5134. PubMed

Ackley MC, Barry CG, Mounce AM, Farmer MC, Springer BE, Day CS, Wright MW, Berners-Price SJ, Hess SH, Bierbach U. Structure–activity relationships in platinum–acridinylthiourea conjugates: effect of the thiourea nonleaving group on drug stability, nucleobase affinity, and in vitro cytotoxicity. J Biol Inorg Chem. 2004;9:453 – 461. PubMed

Zehnulova J, Kasparkova J, Farrell N, Brabec V. Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair of DNA intrastrand cross-links of novel antitumor trinuclear platinum complex BBR3464. J Biol Chem. 2001;276:22191–22199. PubMed

Kasparkova J, Zehnulova J, Farrell N, Brabec V. DNA interstrand cross-links of the novel antitumor trinuclear platinum complex BBR3464. Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair. J Biol Chem. 2002;277:48076–48086. PubMed

Malina J, Hofr C, Maresca L, Natile G, Brabec V. DNA interactions of antitumor cisplatin analogs containing enantiomeric amine ligands. Biophys J. 2000;78:2008–2021. PubMed PMC

Brabec V. Chemistry and structural biology of 1,2-interstrand adducts of cisplatin. In: Kelland LR, Farrell NP, editors. Platinum-based Drugs in Cancer Therapy. Humana Press Inc; Totowa/NJ: 2000. pp. 37–61.

Kasparkova J, Novakova O, Farrell N, Brabec V. DNA binding by antitumor trans- [PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts. Biochemistry. 2003;42:792–800. PubMed

Loskotova H, Brabec V. DNA interactions of cisplatin tethered to the DNA minor groove binder distamycin. Eur J Biochem. 1999;266:392–402. PubMed

Pilch DS, Dunham SU, Jamieson ER, Lippard SJ, Breslauer KJ. DNA sequence context modulates the impact of a cisplatin 1,2-d(GpG) intrastrand cross-link an the conformational and thermodynamic properties of duplex DNA. J Mol Biol. 2000;296:803–812. PubMed

Hofr C, Brabec V. Thermal stability and energetics of 15-mer DNA duplex interstrand cross-linked by trans-diamminedichloroplatinum(II) Biopolymers. 2005;77:222–229. PubMed

Malina J, Novakova O, Vojtiskova M, Natile G, Brabec V. Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog. Biophys J. 2007;93:3950–3962. PubMed PMC

Bursova V, Kasparkova J, Hofr C, Brabec V. Effects of monofunctional adducts of platinum(II) complexes on thermodynamic stability and energetics of DNA duplexes. Biophys J. 2005;88:1207–1214. PubMed PMC

Marky LA, Breslauer KJ. Calculating thermodynamic data for transitions of any molecularity from equilibrium melting curves. Biopolymers. 1987;26:1601–1620. PubMed

Rao L, West TK, Saluta G, Kucera GL, Bierbach U. Probing platinumadenine- N3 adduct formation with DNA minor-groove binding agents. Chem Res Toxicol. 2010;23:1148–1150. PubMed PMC

Wei M, Burenkova O, Lippard SJ. Cisplatin sensitivity in Hmgb1(−/−) and Hmgb1 mouse cells. J Biol Chem. 2003;278:1769–1773. PubMed

Weaver D, Crawford E, Warner K, Elkhairi F, Khuder S, Willey J. ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines. Mol Cancer. 2005;4:18. PubMed PMC

Fujii T, Toyooka S, Ichimura K, Fujiwara Y, Hotta K, Soh J, Suehisa H, Kobayashi N, Aoe M, Yoshino T, Kiura K, Date H. ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer. Lung Cancer. 2008;59:377–384. PubMed

Missura M, Buterin T, Hindges R, Hubscher U, Kasparkova J, Brabec V, Naegeli H. Double-check probing of DNA bending and unwinding by XPA-RPA: an architectural function in DNA repair. EMBO J. 2001;20:3554–3564. PubMed PMC

Lovejoy KS, Todd RC, Zhang SZ, McCormick MS, D’Aquino JA, Reardon JT, Sancar A, Giacomini KM, Lippard SJ. cisdiammine( pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects. Proc Natl Acad Sci USA. 2008;105:8902–8907. PubMed PMC

Wang D, Zhu G, Huang X, Lippard SJ. X-ray structure and mechanism of RNA polymerase II stalled at an antineoplastic monofunctional platinum-DNA adduct. Proc Natl Acad Sci USA. 2010;107:9584–9589. PubMed PMC

Processing and Bypass of a Site-Specific DNA Adduct of the Cytotoxic Platinum-Acridinylthiourea Conjugate by Polymerases Involved in DNA Repair: Biochemical and Thermodynamic Aspects

Thermodynamic Insights by Microscale Thermophoresis into Translesion DNA Synthesis Catalyzed by DNA Polymerases Across a Lesion of Antitumor Platinum-Acridine Complex